0001209191-23-049943.txt : 20230919
0001209191-23-049943.hdr.sgml : 20230919
20230919161927
ACCESSION NUMBER: 0001209191-23-049943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230918
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gerber Hans-Peter
CENTRAL INDEX KEY: 0001992979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 231264045
MAIL ADDRESS:
STREET 1: C/O SUTRO BIOPHARMA, INC.
STREET 2: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-18
0
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001992979
Gerber Hans-Peter
C/O SUTRO BIOPHARMA, INC.
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
0
Stock Option (right to buy)
3.77
2023-09-18
4
A
0
175000
0.00
A
2033-09-18
Common Stock
175000
175000
D
Restricted Stock Unit (RSU)
2023-09-18
4
A
0
150000
0.00
A
2027-09-18
Common Stock
150000
150000
D
25% of the option award vests on September 18, 2024. The remainder vests ratably as to 1/48th of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
The RSU award vests annually as to 1/4th of the total award beginning on September 18, 2024, subject to the reporting person's continued service to the Issuer on each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Hans-Peter Gerber
2023-09-19